Michael Rapp's Net Worth
$37.6 Million
Who is Michael Rapp?
Michael Rapp has an estimated net worth of $37.6 Million. This is based on reported shares across multiple companies, which include COMMITTED CAPITAL ACQUISITION Corp, Immunome Inc., Zynerba Pharmaceuticals, Inc., PLASTRON ACQUISITION CORP I, PLASTRON ACQUISITION CORP III, and PLASTRON ACQUISITION CORP IV.
SEC CIK
Michael Rapp's CIK is 0001405685
Past Insider Trading and Trends
2021 was Michael Rapp's most active year for acquiring shares with 8 total transactions. Michael Rapp's most active month to acquire stocks was the month of September. 2011 was Michael Rapp's most active year for disposing of shares, totalling 2 transactions. Michael Rapp's most active month to dispose stocks was the month of March. 2023 saw Michael Rapp paying a total of $1,569,993.46 for 277,806 shares, this is the most they've acquired in one year. In 2011 Michael Rapp cashed out on 2,303,802 shares for a total of $7,441.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COMMITTED CAPITAL ACQUISITION Corp (STKS) Snapshot price: $3.94
President and Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.65% | 163.06K |
$5.00 | $815,280.00 | 1.56M |
Oct 16
| |||
Form 4
| -5.72% | -197.25K |
—
|
—
| 3.25M |
Apr 23
| |||
Form 4
| -2.36% | -82.75K |
—
|
—
| 3.43M |
Jun 19
| |||
Form 4
| -2.38% | -89.79K |
—
|
—
| 3.68M |
Mar 1
| |||
Form 4
| -37.25% | -2.28M |
—
|
—
| 3.85M |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Immunome Inc. (IMNM) Snapshot price: $25.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.05% | 253.81K |
$5.91 | $1,499,993.46 | 1.07M |
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +2.19% | 17.5K |
$4.00 | $70,000.00 | 817.37K |
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +14.20% | 25.96K |
$19.96 | $518,201.52 | 208.74K |
Sep 13
| |||
Form 4
| +33.58% | 45.95K |
$18.07 | $830,448.60 | 182.78K |
Sep 9 - Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +64.20% | 53.5K |
$18.38 | $983,423.06 | 136.83K |
May 24 - May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
∞
| 638.89K |
$12.00 |
—
| 638.89K |
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Zynerba Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.39% | 5.88K |
$10.45 | $61,498.25 | 1.5M |
May 30
| |||
Form 4
| +1.01% | 15K |
$10.46 | $156,945.00 | 1.49M |
May 2
| |||
Form 4
| +0.68% | 10K |
$9.28 | $92,790.00 | 1.48M |
Mar 22
| |||
Form 4
| +1.03% | 15K |
$12.99 | $194,847.00 | 1.47M |
Jan 2
| |||
Form 4
| +7.38% | 100K |
$9.74 | $973,738.05 | 1.45M |
Oct 19 - Oct 23
| |||
Form 4
| +0.74% | 10K |
$15.85 | $158,500.00 | 1.35M |
Dec 29
| |||
Form 4
| +6.37% | 80.47K |
—
|
—
| 1.34M |
Feb 2
| |||
Form 4
| +81.52% | 567.5K |
—
|
—
| 1.26M |
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PLASTRON ACQUISITION CORP I No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PLASTRON ACQUISITION CORP III No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |